EP
CARM

Eversept Partners’s Carisma Therapeutics CARM Stock Holding History

Eversept Partners’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-77,991
Closed -$2.11M – 92
2020
Q4 		$2.11M Hold
77,991
– – 0.25% 42
2020
Q3 		$2.18M Sell
77,991
-22,009
-22% -$440K 0.49% 36
2020
Q2 		$1.44M Buy
100,000
+35,000
+54% +$472K 0.24% 56
2020
Q1 		$729K Hold
65,000
– – 0.19% 50
2019
Q4 		$1.35M Buy
+65,000
New +$1.49M 0.27% 58

Other funds holding CARM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return